AMEX · LGHT
Langar Global Healthtech ETF
Financial Services · Asset Management
$10.05
Down-$0.07 (-0.71%)
Updated Sep 18, 2026, 9:59 PM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.22M
- P/E ratio
- —
- Dividend yield
- —
- 52-week range
- $7.94 – $11.01
- Volume
- 1.56K
- Avg. volume
- 893
Price performance
LGHT price history
1M range · 20 trading sessions · Daily adjusted prices
LGHT closed at $10.05 after 20 trading sessions, down 0.08% for the selected period.
- Last close
- $10.05
- Period change
- -0.08%
- Period low
- $9.65
- Period high
- $10.32
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $9.93 | $10.09 | $9.93 | $10.0517 | 1.56K |
| Sep 16, 2026 | $9.90 | $9.97 | $9.884 | $9.884 | 6.32K |
| Sep 15, 2026 | $9.87 | $9.93 | $9.86 | $9.8876 | 2.02K |
| Sep 14, 2026 | $9.7809 | $9.9238 | $9.7809 | $9.9238 | 1.65K |
| Sep 11, 2026 | $9.77 | $9.77 | $9.7424 | $9.7424 | 383.11 |
| Sep 10, 2026 | $9.65 | $9.6515 | $9.6201 | $9.6515 | 607.65 |
| Sep 9, 2026 | $9.8236 | $9.8236 | $9.6839 | $9.6839 | 464.31 |
| Sep 8, 2026 | $9.92 | $9.92 | $9.83 | $9.83 | 1.08K |
| Sep 4, 2026 | $10.11 | $10.1139 | $10.10 | $10.1139 | 843.31 |
| Sep 3, 2026 | $10.2443 | $10.2443 | $10.2443 | $10.2443 | 234.4 |
| Sep 2, 2026 | $10.36 | $10.36 | $10.2601 | $10.2605 | 701.4 |
| Sep 1, 2026 | $10.26 | $10.26 | $10.244 | $10.244 | 199.27 |
| Aug 31, 2026 | $10.1199 | $10.2195 | $10.105 | $10.2195 | 1.4K |
| Aug 28, 2026 | $10.179 | $10.18 | $10.13 | $10.163 | 4.87K |
| Aug 27, 2026 | $10.21 | $10.2152 | $10.21 | $10.2152 | 464.94 |
| Aug 26, 2026 | $10.20 | $10.20 | $10.14 | $10.1775 | 1.5K |
| Aug 25, 2026 | $9.71 | $10.35 | $9.71 | $10.3174 | 4.52K |
| Aug 24, 2026 | $10.14 | $10.145 | $10.1001 | $10.145 | 2.35K |
| Aug 21, 2026 | $9.93 | $10.3302 | $9.93 | $10.27 | 5.74K |
| Aug 20, 2026 | $11.01 | $11.01 | $10.06 | $10.06 | 9.32K |
Latest LGHT news
The latest Smart Investors Daily articles mentioning LGHT.
Stock researchCompany · Overview
LGHT research
Overview
Company profile and research snapshot.
Company profile
Under normal circumstances, the fund will invest at least 80% of the fund’s net assets (plus borrowings for investment purposes) in U.S. and foreign exchange-listed equity securities of healthcare technology companies and American Depository Receipts (“ADRs”) on those securities. These securities may be of any market capitalization. The fund is non-diversified.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
